Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract

Review proposal consultation: 1

Stakeholder matrix (PDF 94 KB)

Review proposal paper (PDF 228 KB)

TA272 Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: press release information

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: equality impact assessment - guidance development (PDF 78 KB)

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: second appeal (rejected) information

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: appeal from Pierre Fabre Ltd

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - appeal received (PDF 426 KB)

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - initial scrutiny letter (PDF 45 KB)

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - response to the initial scrutiny (PDF 165 KB)

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: Pierre Fabre Ltd - final scrutiny (PDF 85 KB)

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: final appraisal determination 2 information

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: final appraisal determination 2 (PDF 227 KB)

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: final scope (PDF 19 KB)

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: final appraisal determination (March 2011) (PDF 328 KB)

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: final appeal panel decision (PDF 151 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: appeal information

Transitional cell carcinoma of the urothelial tract - vinflunine: appeal decision (PDF 154 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: appeal announcement information

Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre Ltd - appeal received (PDF 107 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre Ltd - initial scrutiny letter (PDF 50 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre Ltd - response to scrutiny letter (PDF 198 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre Ltd - final scrutiny letter (PDF 20 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: register to attend the appeal information

Transitional cell carcinoma of the urothelial tract - vinflunine: notice of appeal information

Transitional cell carcinoma of the urothelial tract - vinflunine: final appraisal determination  information

Transitional cell carcinoma of the urothelial tract - vinflunine: final appraisal determination document (PDF 225 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: response to consultee, commentator and public comments on the ACD and comments from website consultation (PDF 116 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: consultee and commentator comments on the ACD

Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre (PDF 150 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: Action on Bladder Cancer (PDF 63 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: British Uro-oncology Group (PDF 69 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: joint response from NCRI/Royal College of Physicians/RCR/ACP/JCCO (PDF 73 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: NHS Norfolk (PDF 30 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: appraisal consultation

Transitional cell carcinoma of the urothelial tract - vinflunine: appraisal consultation document information

Transitional cell carcinoma of the urothelial tract - vinflunine: evaluation report

Transitional cell carcinoma of the urothelial tract - vinflunine: pre-meeting briefing (PDF 158 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: Evidence Review Group report (PDF 554 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: Evidence Review Group report - factual accuracy check (PDF 187 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: non-manufacturer submissions

Transitional cell carcinoma of the urothelial tract - vinflunine: Royal College of Pathologists (PDF 49 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: Royal College of Physicians (PDF 107 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre (PDF 2.64 MB)

Transitional cell carcinoma of the urothelial tract - vinflunine: clarification letters

Transitional cell carcinoma of the urothelial tract - vinflunine: NICE request for clarification (PDF 87 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: Pierre Fabre response to clarification request (PDF 129 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: outstanding response to clarification request (PDF 25 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: Birtle (PDF 63 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: final scope (PDF 25 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: final matrix of consultees and commentators (PDF 31 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: Institute's response to consultee and commentator comments on the draft scope (PDF 60 KB)

Transitional cell carcinoma of the urothelial tract - vinflunine: Institute's response to consultee and commentator comments on the provisional matrix (PDF 18 KB)